The Cigna Group vs Eli Lilly & Co.
CI vs LLY — side-by-side comparison from reported financials. CI leads 4, LLY leads 8 of 12 comparable metrics.
The Cigna Group
CI · Healthcare
$282.43+0.50%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | CI | LLY |
|---|---|---|
| Price | $282.43 | $1 177.20 |
| Market cap | $74.6B | $1.05T |
| Revenue (TTM) | $282B | $79.7B |
| Revenue growth | +15.1% | +31.7% |
| Net margin | 2.3% | 33.5% |
| Free cash flow | $10.3B | $18.2B |
| Net cash (debt) | ($22.7B) | ($35.2B) |
| 1-year price return | -7.7% | +37.6% |
| P/E | 11.6 | 41.6 |
| P/E vs own history (cheap-side %) | 80% | 88% |
| Dividend yield | 2.18% | 0.52% |
| Return on equity | 15% | 93% |
| Altman Z-score | 1.77 | 7.10 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 67,700 | 50,000 |
Full résumé-style profiles: CI CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.